Skip to main content
. 2023 Jan 20;15(3):654. doi: 10.3390/cancers15030654
Adoptive Cell Transfer ACT
Adverse Event AE
Angiopoietin 2 ANG2
Antigen-Presenting Cell APC
Barcelona Clinic HCC BCLC
Chimeric Antigen Receptor T Cell CAR-T Cell
Cytokine-Induced Killer Cell CIK
Cytotoxic T-Lymphocyte CTL
Cytotoxic T Lymphocyte-Associated Antigen 4 CTLA-4
Dendritic Cell DC
Disease Control Rate DCR
ECOG Performance Status ECOG
Hepatocellular Carcinoma HCC
Immune Checkpoints ICPs
Intercellular adhesion molecule 1 ICAM1
Lymphocyte Activation Gene-3 LAG-3
Major Histocompatibility Complex Class 1 MHC-1
Median Time to Progression mTTP
Monoclonal Antibody mAb
Natural Killer Cell NK
Notch pathway-related genes NPRGs
Objective Response Rate ORR
Overall Survival OS
Programmed Cell Death 1 PD-1
Progression-Free Survival PFS
Regulatory T Cell Treg
Stem/progenitor cells FLSPCs
T Cell Receptor TCR
T-Cell Immunoglobulin Mucin-3 TIM-3
Transforming Growth Factor-Β TGF-Β
Tumor-Associated Antigen TAA
Tumor-Infiltrating Lymphocyte TIL
Tumor-Associated Macrophage TAM
Tumor Microenvironment TME